MedTrace Logo

Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy

NCT02652000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-12-13

No results posted yet for this study

Summary

Retrospective study to analyze Quality of life in men after iodine seed brachytherapy for localized prostate cancer

Conditions

  • Neoplasms, Prostate

Interventions

OTHER

No intervention in this retrospective study

No Intervention in this retrospective Analysis.

Sponsors & Collaborators

  • University of Zurich

    collaborator OTHER

  • Kantonsspital Graubuenden

    lead OTHER

Principal Investigators

  • Daniel R Zwahlen, MD, MBA · Kantonsspital Graubuenden

Eligibility

Min Age
48 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02652000 on ClinicalTrials.gov